vs

Side-by-side financial comparison of Ovid Therapeutics Inc. (OVID) and 17 Education & Technology Group Inc. (YQ). Click either name above to swap in a different company.

17 Education & Technology Group Inc. is the larger business by last-quarter revenue ($1.2M vs $718.0K, roughly 1.6× Ovid Therapeutics Inc.).

McGraw Hill, Inc. is an American education science company that provides educational content, software, and services for students and educators across various levels—from K-12 to higher education and professional settings. They produce textbooks, digital learning tools, and adaptive technology to enhance learning experiences and outcomes. It is one of the "big three" educational publishers along with Houghton Mifflin Harcourt and Pearson Education. McGraw Hill also publishes reference and tra...

OVID vs YQ — Head-to-Head

Bigger by revenue
YQ
YQ
1.6× larger
YQ
$1.2M
$718.0K
OVID

Income Statement — Q4 FY2025 vs Q3 FY2024

Metric
OVID
OVID
YQ
YQ
Revenue
$718.0K
$1.2M
Net Profit
$-342.2K
Gross Margin
60.9%
Operating Margin
-36.3%
Net Margin
-29.2%
Revenue YoY
844.7%
Net Profit YoY
204.4%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OVID
OVID
YQ
YQ
Q4 25
$718.0K
Q3 25
$132.0K
Q2 25
$6.3M
Q1 25
$130.0K
Q4 24
$76.0K
Q3 24
$173.0K
$1.2M
Q2 24
$169.0K
$1.3M
Q1 24
$148.0K
Net Profit
OVID
OVID
YQ
YQ
Q4 25
Q3 25
$-12.2M
Q2 25
$-4.7M
Q1 25
$-10.2M
Q4 24
Q3 24
$-14.0M
$-342.2K
Q2 24
$8.5M
$-1.1M
Q1 24
$-11.7M
Gross Margin
OVID
OVID
YQ
YQ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
60.9%
Q2 24
16.0%
Q1 24
Operating Margin
OVID
OVID
YQ
YQ
Q4 25
Q3 25
-9487.1%
Q2 25
-80.9%
Q1 25
-9653.8%
Q4 24
Q3 24
-7645.1%
-36.3%
Q2 24
-12140.2%
-89.2%
Q1 24
-11768.2%
Net Margin
OVID
OVID
YQ
YQ
Q4 25
Q3 25
-9210.6%
Q2 25
-74.7%
Q1 25
-7873.1%
Q4 24
Q3 24
-8096.0%
-29.2%
Q2 24
5042.0%
-82.5%
Q1 24
-7901.4%
EPS (diluted)
OVID
OVID
YQ
YQ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-0.20
Q2 24
$0.12
Q1 24
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OVID
OVID
YQ
YQ
Cash + ST InvestmentsLiquidity on hand
$13.2M
$38.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$130.7M
$7.9M
Total Assets
$150.9M
$76.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OVID
OVID
YQ
YQ
Q4 25
$13.2M
Q3 25
$20.6M
Q2 25
$28.4M
Q1 25
$21.1M
Q4 24
$26.3M
Q3 24
$15.0M
$38.7M
Q2 24
$29.7M
$48.2M
Q1 24
$30.8M
Stockholders' Equity
OVID
OVID
YQ
YQ
Q4 25
$130.7M
Q3 25
$44.7M
Q2 25
$55.8M
Q1 25
$59.3M
Q4 24
$68.2M
Q3 24
$76.3M
$7.9M
Q2 24
$88.9M
$7.9M
Q1 24
$78.3M
Total Assets
OVID
OVID
YQ
YQ
Q4 25
$150.9M
Q3 25
$63.8M
Q2 25
$77.4M
Q1 25
$81.7M
Q4 24
$92.2M
Q3 24
$102.7M
$76.7M
Q2 24
$118.1M
$81.2M
Q1 24
$131.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OVID
OVID
YQ
YQ
Operating Cash FlowLast quarter
$-38.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OVID
OVID
YQ
YQ
Q4 25
$-38.3M
Q3 25
$-12.9M
Q2 25
$-4.8M
Q1 25
$-10.3M
Q4 24
$-56.0M
Q3 24
$-15.0M
Q2 24
$-14.3M
Q1 24
$-16.7M
Free Cash Flow
OVID
OVID
YQ
YQ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-56.0M
Q3 24
$-15.0M
Q2 24
$-14.3M
Q1 24
$-16.7M
FCF Margin
OVID
OVID
YQ
YQ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-73719.7%
Q3 24
-8676.9%
Q2 24
-8455.0%
Q1 24
-11287.2%
Capex Intensity
OVID
OVID
YQ
YQ
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
93.4%
Q3 24
2.3%
Q2 24
20.1%
Q1 24
12.8%
Cash Conversion
OVID
OVID
YQ
YQ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.67×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons